Industry News (Patents and Technology)

Patent Issued for Maspin, a Tumor Suppressor Protein In Breast Tissue

Published in Cancer Weekly, February 19th, 1996

LXR Biotechnology Inc. (LXR), Richmond, California, announced that the U.S. Patent and Trademark Office issued a patent covering Maspin, a tumor suppressor protein in breast tissue.

The protein was discovered by a group of scientists headed by Dr. Ruth Sager of the Dana-Farber Cancer Institute, Boston, Massachusetts. The team of researchers at Dana-Farber, in collaboration with scientists from LXR Biotechnology, reported that Maspin levels in highly metastatic breast tumors are greatly reduced.

As acknowledged by the U.S. National Cancer Institute (NCI) in its 1996 Bypass Budget, Maspin gene activity may serve as a prognostic marker for the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1996-02-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry